Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

British Journal of Cancer

Topics

Medicine

Cancer Oncology

Internal Medicine

Urology

Surgery

Show all topics

DOI

10.1038/s41416-018-0310-8

License

CC-BY

Other Formats

PDF